American Renal Associates launches investigative site network

By Maggie Lynch

- Last updated on GMT

(Image: Getty/iLex)
(Image: Getty/iLex)

Related tags Clinical trial Research Kidney Site selection Clinical trial management Clinical trial participants

The American Renal Associates has initiated an investigative site network to bring clinical research to patients while delivering care – and study management services to CROs and sponsors.

Ann Mooney, VP of clinical research at American Renal Associates told us, that the investigative site network is comprised of nephrologists and a dedicated study coordinator to expand upon research.

“The development of a research program was a natural extension of the ARA commitment to improve the care of kidney patients and foster physician autonomy,”​ said Mooney.

The American Renal Clinical Research Services (ARCRS), will provide physician partners and sponsors with the opportunity to bring research to kidney care patients.

Mooney further explained, “We believe it is our moral imperative to advance the care of kidney patients through research.”

“A centrally coordinated, renal specialty research program allows for more expansive offering of research participation to kidney patients across our organization. It also provides CROs [contract research organizations] and sponsors with more efficient and streamlined processes when deploying a study in the dialysis and chronic kidney disease [CKD] settings.”

According to Mooney, the ARCRS will provide a full suite of site network oversight for investigators. It will also offer study management services to CROs and sponsors.

Renal research has been expanding across the US, as researchers aim to gain a greater understanding of the disease and potential treatments. In August 2018 Frenova Renal Research, a CRO specializing in renal research established a site in Louisiana where CKD is highly prevalent​. Frenova has expanded its sites​ over the years, and research centers like High Point Clinical Trials​ Center opened specific trial sites to expand the renal research network​.

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us

Products

View more

Webinars